Products

VueXYZ

Creative Coding Composables for Vue 3

vuexyz.org SourceSoftware Development / Developer Utilities

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Simon Le Marchant
@marchantweb· 9,050 followers
Launched
2y ago
2024-03-05 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Show HN (27 pts · 2 comments)Launch

    VueXYZ – Creative coding composables for Vue 3

    Mar 5, 2024 · 2y agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Agent, MCP & Developer Integration

CLI / SDK
Integration docs
Browse developer & CLI tools →

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-02-05

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-07-31

Key pages

Weekly snapshots
Home
vuexyz.org/ Snapshot 2026-11-16

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does VueXYZ get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is VueXYZ and what platforms does it support?
VueXYZ is catalogued under Developer Utilities: Creative Coding Composables for Vue 3. Supported platforms: CLI / SDK.
Is VueXYZ open source?
VueXYZ has a public repository (https://github.com/vuexyz/vuexyz) with its source repository published.Source

Related products in this category

Software Development / Developer Utilities

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.